Skip to main content

Table 1 Characteristics of obese patients and controls

From: The Pro12Ala polymorphism in the PPAR-γ2 gene is not associated to obesity and type 2 diabetes mellitus in a Cameroonian population

Parameters Cases (n = 62) Controls (n = 60) p value
Age (years) 43 (11) 34 (12) <0.001
BMI (Kg/m2) 34.22 (4.62) 22.10 (1.70) <0.001
WHR 0.86 (0.07) 0.81 (0.06) <0.001
FPG (mg/dL) 96.81 (11.74) 92.03 (11.08) 0.027
SBP (mmHg) 131.13 (20.05) 116.98 (16.45) <0.001
DBP (mmHg) 80.53 (10.90) 70.77 (10.97) <0.001
T-C (mg/L) 190.5 (35.89) 180.68 (26.85) 0.040
TG (mg/dL) 135.79 (19.47) 131.81 (18.26) 0.247
HDL-C (mg/dL) 49.02 (7.89) 47.89 (5.37) 0.360
LDL-C (mg/dL) 114.84 (33.29) 106.46 (25.02) 0.119
AI 3.93 (0.68) 3.80 (0.62) 0.293
  1. Data are expressed as mean (standard deviation)
  2. FPG Fasting Plasma Glucose, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, TG triglycerides, AI Atherogenic index = total cholesterol/HDL-cholesterol